In the early 1970s, responding to mounting evidence that airborne lead posed significant health risks—especially to children—the EPA promulgated regulations under Section 211(c) of the Clean Air Act to reduce the amount of tetraethyl lead in gasoline. The agency compiled a voluminous record documenting the toxicity of lead, the contribution of motor vehicle emissions to ambient lead levels and human blood-lead burdens, and the particular vulnerability of urban populations and children to neurological and developmental harm at relatively low exposures. EPA concluded that emissions from leaded gasoline significantly contributed to public exposure to lead and that continued use of lead additives would endanger public health. Ethyl Corporation—a major producer of tetraethyl lead—along with other industry petitioners, challenged EPA's statutory authority and the sufficiency of its scientific basis, arguing that the evidence of harm from then-current ambient levels was inconclusive, that the statute did not authorize the regulation in question, and that the rulemaking was procedurally and substantively defective under the APA.
Does the Clean Air Act authorize the EPA to restrict lead additives in gasoline upon a finding that emissions from those additives will endanger public health, even in the face of scientific uncertainty, and was the agency's rulemaking arbitrary or capricious under the APA?
Under Section 211(c)(1)(A) of the Clean Air Act, the EPA Administrator may control or prohibit any fuel or fuel additive if, in his judgment, any emission product of such fuel or additive will endanger the public health or welfare. Judicial review of such informal rulemaking proceeds under the APA's arbitrary-and-capricious standard, which requires that the agency examine the relevant data, consider significant comments and alternatives, and articulate a satisfactory explanation establishing a rational connection between the facts found and the choice made. The endangerment standard is preventive: the EPA need not wait for proof of actual harm but may regulate based on a reasonable assessment of significant risk and potential harm, especially when public health and vulnerable subpopulations are at stake.
The D.C. Circuit (en banc) upheld the EPA's lead-content regulations. The court held that Section 211(c) authorizes preventive regulation of fuel additives upon a reasonable endangerment finding; that the EPA reasonably concluded emissions from leaded gasoline would endanger public health; and that the rulemaking was not arbitrary or capricious.
Statutory authority: The court read Section 211(c)'s text—particularly "in his judgment" and "will endanger the public health or welfare"—as conferring broad discretion to make predictive, expert judgments to prevent harm. The legislative history confirmed Congress's intent to address fuel-related threats to health proactively, acknowledging scientific uncertainty and the special risks posed by toxic substances like lead. Scientific uncertainty and endangerment: The court emphasized that a preventive statute aimed at protecting health does not require conclusive proof of injury before regulation. Waiting for scientific certainty in the face of credible risk would undermine the statute's protective purpose. The EPA reasonably relied on the cumulative weight of evidence: toxicology establishing lead's harmful effects; epidemiological and environmental data connecting vehicular emissions to ambient lead; and studies showing elevated blood-lead levels and heightened susceptibility among children and urban residents. The court approved the agency's attention to vulnerable subpopulations and low-level, chronic exposures, finding it reasonable to act conservatively where the magnitude of possible harm is substantial and irreversibility is a concern. APA review—"hard look" scrutiny: Applying arbitrary-and-capricious review, the court took a hard look to ensure the EPA examined relevant data, responded to significant comments, and explained its choices, including the phasedown approach and the rejection of proposed alternatives. While the record reflected uncertainty and some conflicting studies, the agency identified the limitations of the data, explained its methodological choices (including reliance on a weight-of-evidence risk assessment rather than definitive dose–response thresholds), and reasonably connected the evidence to the regulatory limits selected. The court rejected claims that the EPA was required to wait for more definitive studies or to adopt trial-type procedures, holding that notice-and-comment rulemaking provided adequate process and that the agency's predictive judgments fell well within its statutory mandate. Petitioners' objections: The court dismissed arguments that other lead sources, rather than gasoline, were primarily responsible for exposure; Section 211(c) authorizes regulation where a fuel or its emissions contribute to air pollution that endangers health. It also rejected the contention that the EPA had to quantify precise risk levels or prove actual current harm. Finally, while acknowledging economic impacts, the court held that the statute prioritizes health protection and that the EPA had reasonably considered feasibility in crafting a phased reduction.
Ethyl cements two enduring propositions. Substantively, it affirms that agencies charged with protecting public health may regulate proactively under an endangerment standard, relying on the best available science and reasonable inferences amid uncertainty. Procedurally, it is a leading articulation of "hard look" review: courts require reasoned decision-making but do not demand certainty or impose extra-statutory procedures. For law students, the case illuminates how statutory text ("in his judgment," "will endanger"), scientific evidence, and APA review interact in major health-protective rulemakings, foreshadowing later debates about risk, deference, and precaution in administrative law.
Ethyl Corp. v. EPA is a cornerstone of preventive environmental regulation and administrative law. It affirms that Congress can empower agencies to act on credible risk—before damage is done—when public health is on the line, and that courts should review such actions for reasoned decision-making rather than scientific certitude.